Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MTBC Stock Forecast 2026-2027
$2.35
Current Price
$0
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MTBC Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MTBC Price Momentum
0.0%
1 Week Change
+7.3%
1 Month Change
-4.9%
1 Year Change
-19.5%
Year-to-Date Change
-41.5%
From 52W High of $4.01
+15.0%
From 52W Low of $2.04
📊 TOP ANALYST CALLS
Did MTBC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if MTBC is one of their latest high-conviction picks.
Latest MTBC Stock Price Targets & Analyst Predictions
MTBC has shown a year-to-date change of -19.5% and a 1-year change of -4.9%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MTBC. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MTBC Analyst Ratings
1
Buy
0
Hold
0
Sell
MTBC Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $2.35
Latest MTBC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MTBC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 13, 2022 | Maxim Group | Allen Klee | Buy | Maintains | $12.00 |
| Mar 15, 2022 | B. Riley Securities | Marc Wiesenberger | Buy | Maintains | $11.00 |
| Jun 11, 2021 | Cantor Fitzgerald | Overweight | Initiates | $N/A | |
| Nov 25, 2020 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Nov 25, 2020 | Benchmark | Buy | Initiates | $N/A | |
| Nov 25, 2020 | Ladenburg Thalmann | Buy | Initiates | $N/A | |
| Nov 25, 2020 | B. Riley FBR | Buy | Maintains | $N/A | |
| Nov 25, 2020 | H.C. Wainwright | Neutral | Downgrade | $N/A | |
| Nov 25, 2020 | B. Riley | Buy | Initiates | $N/A | |
| Nov 25, 2020 | National Securities | Buy | Initiates | $N/A | |
| Nov 25, 2020 | Chardan Capital | Buy | Maintains | $N/A | |
| Nov 25, 2020 | Summer Street | Buy | Initiates | $N/A | |
| Aug 18, 2020 | HC Wainwright & Co. | Buy | Maintains | $14.00 | |
| May 15, 2020 | B. Riley Securities | Buy | Maintains | $8.50 | |
| Nov 14, 2017 | Chardan Capital | Keay Nakae | Buy | Maintains | $2.75 |
| Feb 23, 2015 | Chardan Capital | Buy | Assumes | $6.25 |
MTBC Inc (MTBC) Competitors
The following stocks are similar to MTBC based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MTBC Inc (MTBC) Financial Data
MTBC Inc has a market capitalization of $0 with a P/E ratio of -3.5x. The company generates $138.83M in trailing twelve-month revenue with a 39.2% profit margin.
Revenue growth is -3.5% quarter-over-quarter, while maintaining an operating margin of +4.3% and return on equity of +35.2%.
Valuation Metrics
Market Cap
$0
Enterprise Value
$1.51M
P/E Ratio
-3.5x
PEG Ratio
N/A
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-3.5%
Gross Margin
+39.9%
Operating Margin
+4.3%
Net Margin
+39.2%
EPS Growth
-13.2%
Financial Health
Cash/Price Ratio
N/A
Current Ratio
3.6x
Debt/Equity
-0.5x
ROE
+35.2%
ROA
-7.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
MTBC Inc (MTBC) Business Model
About MTBC Inc
What They Do
N/A
Business Model
N/A
Additional Information
N/A
Company Information
MTBC Inc (MTBC) Latest News & Analysis
Latest News
Quick Summary
CareCloud, Inc. reports growing demand for its digital health solution, CareCloud Wellness, expected to accelerate throughout 2023.
Why It Matters
Rising demand for CareCloud's digital health solution indicates potential revenue growth, enhancing the company's market position and attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
CareCloud to Host Investor Meetings During the Week of the J.P. Morgan Healthcare Conference
3 years ago
Quick Summary
CareCloud, Inc. will host investor meetings on Jan. 10-11, 2023, during the J.P. Morgan Healthcare Conference in San Francisco, featuring CEO A. Hadi Chaudhry and CFO Bill Korn.
Why It Matters
CareCloud's investor meetings coincide with a major healthcare conference, signaling potential insights into its strategy and performance, which can impact stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CareCloud, Inc. announced that Alpine Ear Nose and Throat PC has chosen its Meridian division's revenue cycle management solution to enhance cash flow and administrative operations.
Why It Matters
CareCloud's partnership with Alpine Ear Nose and Throat PC to enhance revenue cycle management signals growth potential and increased demand for its services, positively influencing investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
CareCloud to Sponsor Association of Physicians of Pakistani Descent of North America's 2022 Winter Meeting
3 years ago
Quick Summary
CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP) is sponsoring the APPNA 2022 winter meeting from Dec. 22-25 at Nishtar Medical University in Multan, Pakistan.
Why It Matters
CareCloud's sponsorship of a key healthcare event signals its commitment to industry engagement, potentially enhancing brand visibility and partnerships, which could drive future growth and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
CareCloud's medSR Division Helps Hospital CIO Earn Recognition for Delivering Reliable Technology Innovation
3 years ago
Quick Summary
CareCloud, Inc. announced that its medSR division contributed to King’s Daughters Medical Center CIO Carl Smith receiving the 2022 Info-Tech CIO Award, highlighting its successful IT strategy.
Why It Matters
Recognition of CareCloud's IT strategy boosts its credibility in the healthcare technology sector, potentially attracting more clients and increasing revenue prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CareCloud leadership highlights company strengths and opportunities, while announcing a change of its Nasdaq symbol from MTBC to CCLD.
Why It Matters
CareCloud's Nasdaq symbol change to CCLD may enhance visibility and attract investor interest, reflecting the company's growth and strategic focus.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MTBC Stock
What is MTBC Inc's (MTBC) stock forecast for 2027?
Analyst forecasts for MTBC Inc (MTBC) are not currently available. The stock is trading at $2.35.
Is MTBC stock a good investment in 2027?
According to current analyst ratings, MTBC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.35. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MTBC stock?
Price predictions from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.35.
What is MTBC Inc's business model?
N/A
What is the highest forecasted price for MTBC MTBC Inc?
Price targets from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.35.
What is the lowest forecasted price for MTBC MTBC Inc?
Price targets from Wall Street analysts for MTBC are not currently available. The stock is trading at $2.35.
What is the overall MTBC consensus from analysts for MTBC Inc?
The overall analyst consensus for MTBC is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are MTBC stock price projections?
Stock price projections, including those for MTBC Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 10:20 AM UTC